Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
ipo
4
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
4
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
novartis
asklepios biopharmaceutical
biogen
cancer immunotherapy
crispr
crispr therapeutics
investing
medical devices
messenger rna
startups
What
new
4
×
bio
ipo
roundup
life
million
science
therapeutics
activity
allogene
approvals
bails
biogen
biotechs
brand
bridgebio
cancer
capital
car
clamped
club
companies
continued
covid
crispr
crop
delays
develop
developing
diversity
drugs
economic
emerges
exceeded
fast
fda
firm
firms
grab
group
Language
unset
Current search:
ipo
×
new
×
" seattle top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M